Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
BMC Public Health|October 29, 2021
Risk factors associated with respiratory infectious disease-related presenteeism: a rapid reviewSarah Daniels, Hua Wei, Yang Han, et al.
Occupational and Environmental Medicine|April 13, 2023
Contact patterns of UK home delivery drivers and their use of protective measures during the COVID-19 pandemic: a cross-sectional studyJessica R E Bridgen, Hua Wei, Carl Whitfield, et al.
Plos One|May 5, 2023
Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sectorCarl A Whitfield, Martie van Tongeren, Yang Han, et al.
BMC Psychiatry|May 1, 2015
Clinical and cost effectiveness of staff training in Positive Behaviour Support (PBS) for treating challenging behaviour in adults with intellectual disability: a cluster randomised controlled trialAngela Hassiotis, Andre Strydom, Mike Crawford, et al.
Plos One|August 23, 2019
Process evaluation of a randomised controlled trial of PBS-based staff training for challenging behaviour in adults with intellectual disabilityAlessandro Bosco, Laura Paulauskaite, Ian Hall, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 31, 2021
Challenges in control of COVID-19: short doubling time and long delay to effect of interventionsLorenzo Pellis, Francesca Scarabel, Helena B Stage, et al.
Thorax|May 10, 2022
Mendelian randomisation of eosinophils and other cell types in relation to lung function and diseaseAnna Guyatt, Catherine John, Alexander T Williams, et al.
Scientific Data|May 14, 2026
Digitization of Historical Data from Somalia's Last Smallpox Outbreaks 1976-1977Rabia Khan, Hannah Williams, Galena Kuyumdzhieva, et al.
Plos Computational Biology|October 24, 2022
Novel methods for estimating the instantaneous and overall COVID-19 case fatality risk among care home residents in EnglandChristopher E Overton, Luke Webb, Uma Datta, et al.
BMC Infectious Diseases|March 21, 2022
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2Karan Pattni, Daniel Hungerford, Sarah Adams, et al.
Pageof 12